Grant Nash Colfax

Summary

Affiliation: San Francisco General Hospital
Country: USA

Publications

  1. pmc Contingency management to reduce methamphetamine use and sexual risk among men who have sex with men: a randomized controlled trial
    Timothy W Menza
    Center for AIDS and STD, Harborview Medical Center, 325 Ninth Avenue, Seattle, WA 98104, USA
    BMC Public Health 10:774. 2010
  2. pmc Mirtazapine to reduce methamphetamine use: a randomized controlled trial
    Grant N Colfax
    San Francisco Department of Public Health, San Francisco, CA 94102, USA
    Arch Gen Psychiatry 68:1168-75. 2011
  3. doi Amphetamine-group substances and HIV
    Grant Colfax
    HIV Prevention Section, San Francisco Department of Public Health, San Francisco, CA 94102, USA
    Lancet 376:458-74. 2010
  4. ncbi Motivations for participating in an HIV vaccine efficacy trial
    Grant Colfax
    San Francisco Department of Public Health, San Francisco, CA 94102 6033, USA
    J Acquir Immune Defic Syndr 39:359-64. 2005
  5. ncbi The methamphetamine epidemic: implications for HIV prevention and treatment
    Grant Colfax
    San Francisco Department of Public Health, 25 Van Ness Avenue, Suite 710, San Francisco, CA 94102, USA
    Curr HIV/AIDS Rep 2:194-9. 2005
  6. ncbi Club drugs and HIV infection: a review
    Grant Colfax
    AIDS Office, HIV AIDS Statistics, Epidemiology, andIntervention Research Section, San Francisco Department of Public Health, San Francisco, California 94102, USA
    Clin Infect Dis 42:1463-9. 2006
  7. pmc Tripling of methamphetamine/amphetamine use among homeless and marginally housed persons, 1996-2003
    Moupali Das-Douglas
    Department of Medicine, Division of Infectious Diseases, University of California, San Francisco, CA 94143, USA
    J Urban Health 85:239-49. 2008
  8. pmc An individually tailored intervention for HIV prevention: baseline data from the EXPLORE Study
    Margaret A Chesney
    School of Medicine, University of California, San Francisco, USA
    Am J Public Health 93:933-8. 2003
  9. ncbi Frequent methamphetamine use is associated with primary non-nucleoside reverse transcriptase inhibitor resistance
    Grant Nash Colfax
    AIDS Office, San Francisco Department of Public Health, San Francisco, California, USA
    AIDS 21:239-41. 2007
  10. ncbi Negative social impacts among volunteers in an HIV vaccine efficacy trial
    Jonathan Fuchs
    AIDS Office, San Francisco Department of Public Health, San Francisco, CA, USA
    J Acquir Immune Defic Syndr 46:362-8. 2007

Detail Information

Publications15

  1. pmc Contingency management to reduce methamphetamine use and sexual risk among men who have sex with men: a randomized controlled trial
    Timothy W Menza
    Center for AIDS and STD, Harborview Medical Center, 325 Ninth Avenue, Seattle, WA 98104, USA
    BMC Public Health 10:774. 2010
    ....
  2. pmc Mirtazapine to reduce methamphetamine use: a randomized controlled trial
    Grant N Colfax
    San Francisco Department of Public Health, San Francisco, CA 94102, USA
    Arch Gen Psychiatry 68:1168-75. 2011
    ..No approved pharmacologic treatments for methamphetamine dependence exist. Methamphetamine use is associated with high morbidity and is a major cofactor in the human immunodeficiency virus epidemic among men who have sex with men (MSM)...
  3. doi Amphetamine-group substances and HIV
    Grant Colfax
    HIV Prevention Section, San Francisco Department of Public Health, San Francisco, CA 94102, USA
    Lancet 376:458-74. 2010
    ..The search for effective, scalable, and sustainable interventions for amphetamine-group substance use, including pharmacotherapies, should be supported and encouraged...
  4. ncbi Motivations for participating in an HIV vaccine efficacy trial
    Grant Colfax
    San Francisco Department of Public Health, San Francisco, CA 94102 6033, USA
    J Acquir Immune Defic Syndr 39:359-64. 2005
    ....
  5. ncbi The methamphetamine epidemic: implications for HIV prevention and treatment
    Grant Colfax
    San Francisco Department of Public Health, 25 Van Ness Avenue, Suite 710, San Francisco, CA 94102, USA
    Curr HIV/AIDS Rep 2:194-9. 2005
    ..Pharmacologic and structural interventions may prove valuable additional interventions to reduce methamphetamine use...
  6. ncbi Club drugs and HIV infection: a review
    Grant Colfax
    AIDS Office, HIV AIDS Statistics, Epidemiology, andIntervention Research Section, San Francisco Department of Public Health, San Francisco, California 94102, USA
    Clin Infect Dis 42:1463-9. 2006
    ....
  7. pmc Tripling of methamphetamine/amphetamine use among homeless and marginally housed persons, 1996-2003
    Moupali Das-Douglas
    Department of Medicine, Division of Infectious Diseases, University of California, San Francisco, CA 94143, USA
    J Urban Health 85:239-49. 2008
    ..Further research is needed to elucidate the most effective prevention and treatment for MA use and dependence among the H/M...
  8. pmc An individually tailored intervention for HIV prevention: baseline data from the EXPLORE Study
    Margaret A Chesney
    School of Medicine, University of California, San Francisco, USA
    Am J Public Health 93:933-8. 2003
    ..We describe the intervention tested in EXPLORE, an HIV prevention trial aimed at men who have sex with men (MSM), and test the empirical basis of the individually tailored intervention...
  9. ncbi Frequent methamphetamine use is associated with primary non-nucleoside reverse transcriptase inhibitor resistance
    Grant Nash Colfax
    AIDS Office, San Francisco Department of Public Health, San Francisco, California, USA
    AIDS 21:239-41. 2007
    ..We postulate that this association may be caused by methamphetamine-associated treatment interruptions among source partners...
  10. ncbi Negative social impacts among volunteers in an HIV vaccine efficacy trial
    Jonathan Fuchs
    AIDS Office, San Francisco Department of Public Health, San Francisco, CA, USA
    J Acquir Immune Defic Syndr 46:362-8. 2007
    ..Describe the negative social impacts (NSIs) and their predictors in an HIV vaccine efficacy trial...
  11. pmc Longitudinal patterns of methamphetamine, popper (amyl nitrite), and cocaine use and high-risk sexual behavior among a cohort of san francisco men who have sex with men
    Grant Colfax
    San Francisco Department of Public Health, HIV Research Branch, 25 Van Ness Avenue, Suite 500, San Francisco, CA 94102 6033, USA
    J Urban Health 82:i62-70. 2005
    ..quot; HIV prevention interventions should target MSM who report either light or heavy use of methamphetamines, poppers, and sniffed cocaine...
  12. ncbi Substance use and sexual risk: a participant- and episode-level analysis among a cohort of men who have sex with men
    Grant Colfax
    San Francisco Department of Public Health, HIV Research Branch, CA, 94102 6033, USA
    Am J Epidemiol 159:1002-12. 2004
    ..The authors concluded that programs aimed at preventing human immunodeficiency virus transmission should emphasize the influence of substance use during sex on increased risk behavior...
  13. doi Anal human papillomavirus infection is associated with HIV acquisition in men who have sex with men
    Peter V Chin-Hong
    Department of Medicine, University of California, San Francisco, San Francisco, California 94143, USA
    AIDS 23:1135-42. 2009
    ..Our aim was to determine the association between anal HPV infection and HIV acquisition...
  14. pmc Prevalence and correlates of unknown HIV infection among patients seeking care in a public hospital emergency department
    Nicola M Zetola
    Division of Infectious Diseases, Department of Medicine, University of California, San Francisco, CA, USA
    Public Health Rep 123:41-50. 2008
    ..To evaluate the potential for the implementation of routine screening, we determined the prevalence of unknown HIV infection among patients being seen in an urban public hospital ED...
  15. ncbi Beliefs about HIV reinfection (superinfection) and sexual behavior among a diverse sample of HIV-positive men who have sex with men
    Grant Nash Colfax
    J Acquir Immune Defic Syndr 36:990-2. 2004

Research Grants13

  1. Mirtazapine to Reduce Methamphetamine Use Among MSM with High-Risk HIV Behaviors
    Grant Colfax; Fiscal Year: 2007
    ..If promising, study results will be used to design a phase III clinical trial to determine if mirtazapine's effects on reducing meth use lead to reductions in meth-associated sexual risk. ..
  2. Acceptability of pharmacologic treatment for methamphetamine dependence among MSM
    Grant Colfax; Fiscal Year: 2006
    ..We include both urine testing and behavioral risk assessments because we anticipate that future efficacy trials will include an HIV prevention focus, analyzing not only substance use but also sexual risk behavior outcomes. ..
  3. Reducing HIV risk among episodic substance-using MSM
    Grant Colfax; Fiscal Year: 2007
    ....
  4. Aripiprazole Treatment for Methamphetamine Dependence Among High-Risk MSM
    Grant Colfax; Fiscal Year: 2007
    ..If promising, study results will be used to design larger, definitive clinical trials to determine the efficacy of aripiprazole in reducing methamphetamine use and corresponding methamphetamine-associated sexual risk among MSM. ..
  5. Aripiprazole to reduce methamphetamine use among MSM with high-risk HIV behaviors
    Grant Colfax; Fiscal Year: 2007
    ....
  6. Club-Drugs and HIV Risk Behavior in High-Risk Men
    Grant Colfax; Fiscal Year: 2007
    ..abstract_text> ..
  7. Aripiprazole to reduce methamphetamine use among MSM with high-risk HIV behaviors
    Grant Colfax; Fiscal Year: 2009
    ....